Search
Creso's flagship product is a cannabinol lozenge.

Creso expands into Sri Lanka

Medicinal cannabis company Creso Pharma has announced it will expand into Sri Lanka, after it signed a binding letter of intent with Ceyoka Health, one of Sri Lanka’s largest pharmaceutical distribution companies.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Creso Pharma (CPH)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/19

1 year TSR5 year TSR
457thParkd-32%
587thNanollose-48%
675thCreso Pharma-58%
712thOpenDNA-64%
838theSense-Lab-89%
726 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

21/08/18
$28k Issued
21/08/18
$138k Issued
21/08/18
$204k Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

189th↑Creso Pharma$244k
201st↑OpenDNA$119k
202nd-Nanollose$117k
204th↑eSense-Lab$108k
205th-Parkd$97k
228 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer